Oncolytic Immunotherapy Firm Replimune Secures $30 Million Series A Funding
Sep 29, 2015 08:05
CST Updated
08:05
1、National Health and Family Planning Commission: Promoting Tiered Diagnosis and Treatment Requires Encouraging the Establishment of Private ClinicsMulti-site Practice for Physicians
At the on-site meeting held in Shanghai on the 25th to advance the development of a tiered diagnosis and treatment system, it was proposed that China should adhere to the principle of voluntary public participation. By leveraging economic incentives, flexible measures, and enhanced publicity, the initiative aims to ensure that the public tangibly experiences the convenience and benefits brought by the tiered diagnosis and treatment system.
Ma Xiaowei, Deputy Director of the National Health and Family Planning Commission, stated that promoting the establishment of a tiered diagnosis and treatment system and improving the basic medical and health care system is the inevitable path to alleviating public difficulties in accessing medical services, deepening the reform of the medical and pharmaceutical systems, and facilitating the transformation and upgrading of healthcare service models.
Efforts should be made to highlight the development of primary healthcare systems by establishing medical consortiums and implementing paired assistance programs,Multi-site Practice for Physicians, encourage the establishment of individual clinics and other measures to enhance the capacity of primary healthcare services, with particular emphasis on strengthening the clinical specialty capabilities of county-level public hospitals; strengthen the development of the workforce in primary healthcare institutions,Strive to ensure that in both urban and rural areas, for every 10,000per resident2to 3A Qualified General Practitioner, and design supporting systems that align with the work characteristics of general practitioners.
2、TevaPharmaceutical Company Acquires Smart Asthma Inhaler Firm Gecko
Israeli generic drug giant Teva Pharmaceuticals to acquire U.S. smart asthma inhaler company Gecko Health Innovations. Specific details of the acquisition have not yet been disclosed.
Gecko’s flagship product is CareTRx, a chronic respiratory disease management platform that includes inhaler-connected sensor devices, a data analytics platform, a user interface, and electronic behavioral triggers to help patients with asthma and chronic obstructive pulmonary disease (COPD) manage their health.
Mark Maalouf and Yechiel Engelahard, founders of Gecko, stated that their collaboration with Teva aims to integrate CareTRx’s technology into Teva’s respiratory product portfolio to improve clinical outcomes.
Teva is the second pharmaceutical company to independently acquire a smart asthma inhaler company. Last year, biopharmaceutical company Opko acquired the Israeli smart asthma inhaler company Inspiron Medical to integrate smart hardware with its app and develop its own chronic disease management platform.
3、Replimune, a Cancer Therapy Research CompanyAcquire 3,000USD 10,000 in financing
Replimune, an Oxford-based cancer research company, recently announced the completion of a $30 million Series A financing round, led by Atlas Venture, with participation from existing investors Forbion Capital Partners and Omega Funds.
Replimune is renowned for developing oncolytic immunotherapies for cancer. Oncolytic immunotherapy is a novel cancer treatment approach that explores how viruses can selectively replicate within the human body to destroy tumor tissue.
4、Medical Image Analysis Platform lifeIMAGEEarn 500$10,000 Strategic Investment
Last Thursday, lifeIMAGE Announces $5 Million Strategic Investment; Previously Raised $17.5 Million in MaylifeIMAGE has announced that it has secured a $5 million strategic investment from Zaffre Investments, a fund under Blue Cross Blue Shield of Massachusetts. This follows the company’s completion of a $17.5 million financing round in May.
lifeIMAGE is a medical imaging exchange platform that integrates its medical imaging network with electronic health record systems Epic and Cerner to achieve data interoperability, and is used by the clinical systems of most large healthcare groups and hospitals in the United States.
At the on-site meeting held in Shanghai on the 25th to advance the development of a tiered diagnosis and treatment system, it was proposed that China should adhere to the principle of voluntary public participation. By leveraging economic incentives, flexible measures, and enhanced publicity, the initiative aims to ensure that the public tangibly experiences the convenience and benefits brought by the tiered diagnosis and treatment system.
Ma Xiaowei, Deputy Director of the National Health and Family Planning Commission, stated that promoting the establishment of a tiered diagnosis and treatment system and improving the basic medical and health care system is the inevitable path to alleviating public difficulties in accessing medical services, deepening the reform of the medical and pharmaceutical systems, and facilitating the transformation and upgrading of healthcare service models.
Efforts should be made to highlight the development of primary healthcare systems by establishing medical consortiums and implementing paired assistance programs,Multi-site Practice for Physicians, encourage the establishment of individual clinics and other measures to enhance the capacity of primary healthcare services, with particular emphasis on strengthening the clinical specialty capabilities of county-level public hospitals; strengthen the development of the workforce in primary healthcare institutions,Strive to ensure that in both urban and rural areas, for every 10,000per resident2to 3A Qualified General Practitioner, and design supporting systems that align with the work characteristics of general practitioners.
2、TevaPharmaceutical Company Acquires Smart Asthma Inhaler Firm Gecko
Israeli generic drug giant Teva Pharmaceuticals to acquire U.S. smart asthma inhaler company Gecko Health Innovations. Specific details of the acquisition have not yet been disclosed.
Gecko’s flagship product is CareTRx, a chronic respiratory disease management platform that includes inhaler-connected sensor devices, a data analytics platform, a user interface, and electronic behavioral triggers to help patients with asthma and chronic obstructive pulmonary disease (COPD) manage their health.
Mark Maalouf and Yechiel Engelahard, founders of Gecko, stated that their collaboration with Teva aims to integrate CareTRx’s technology into Teva’s respiratory product portfolio to improve clinical outcomes.
Teva is the second pharmaceutical company to independently acquire a smart asthma inhaler company. Last year, biopharmaceutical company Opko acquired the Israeli smart asthma inhaler company Inspiron Medical to integrate smart hardware with its app and develop its own chronic disease management platform.
3、Replimune, a Cancer Therapy Research CompanyAcquire 3,000USD 10,000 in financing
Replimune, an Oxford-based cancer research company, recently announced the completion of a $30 million Series A financing round, led by Atlas Venture, with participation from existing investors Forbion Capital Partners and Omega Funds.
Replimune is renowned for developing oncolytic immunotherapies for cancer. Oncolytic immunotherapy is a novel cancer treatment approach that explores how viruses can selectively replicate within the human body to destroy tumor tissue.
4、Medical Image Analysis Platform lifeIMAGEEarn 500$10,000 Strategic Investment
Last Thursday, lifeIMAGE Announces $5 Million Strategic Investment; Previously Raised $17.5 Million in MaylifeIMAGE has announced that it has secured a $5 million strategic investment from Zaffre Investments, a fund under Blue Cross Blue Shield of Massachusetts. This follows the company’s completion of a $17.5 million financing round in May.
lifeIMAGE is a medical imaging exchange platform that integrates its medical imaging network with electronic health record systems Epic and Cerner to achieve data interoperability, and is used by the clinical systems of most large healthcare groups and hospitals in the United States.
